Clinical Trial Update: Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid [NA]

View source ↗

Summary

Clinical trial investigating simvastatin and zoledronic acid for overcoming chemotherapy resistance in refractory multiple myeloma; study terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: University of Louisville | Conditions: Multiple Myeloma | NA | Status: TERMINATED | Results posted: 2019-11-18